Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737678) titled 'Evaluation of NIPSA Using Alloplastic Bone Graft and Cross-Linked Hyaluronic Acid in theTreatment of Intrabony Defects' on July 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Mansoura University
Condition:
Intrabony Periodontal Defect
Periodontal Disease
Intervention:
Device: allopastic bone graft
Drug: cross-linked hyaluronic acid
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: August 1, 2026
Target Sample Size: 60
To know more, visi...